Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FHGLR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,166
Award facts
- Contract value 100% obligated
- $4,165.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,165.86 to DMS Pharmaceutical Group Inc. for the supply of Nexplanon 68 mg implants. This firm fixed-price delivery order, issued on August 6, 2025, with an ultimate completion date of August 27, 2025, was awarded without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. The delivery order is issued under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, which is valued at $499,999,999 and remains valid through November 2026.
DMS Pharmaceutical Group specializes in distributing a comprehensive range of pharmaceutical products to federal healthcare systems, particularly military medical facilities. The company has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing delivery orders for diverse medical products including prescription medications, biologics, and medical consumables. This specific delivery order for Nexplanon implants—a contraceptive device—demonstrates the breadth of DMS Pharmaceutical Group's federal pharmaceutical portfolio and its role in supporting the medical supply requirements of Department of Defense healthcare sites nationwide.
Quick answers
Who was awarded contract SPE2DB25FHGLR?
SPE2DB25FHGLR was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FHGLR worth?
The government has obligated $4,166 on SPE2DB25FHGLR.
Is contract SPE2DB25FHGLR an order under another contract?
Yes. SPE2DB25FHGLR is a delivery order under SPE2DB24D9241, an indefinite delivery contract.
Was contract SPE2DB25FHGLR competed?
The extent of competition for SPE2DB25FHGLR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award